Zosano Pharma Stock News

The FDA has issued a response letter to Zosano Pharma Corp (NASDAQ: ZSAN ) regarding its resubmission of the 505(b)(2) New Drug Application for M207 (zolmitriptan microneedle system). The response letter stated that the FDA did not consider the resubmitted M207 application a complete response to the deficiencies identified in the FDAs October 2020 Complete Response Letter. The FDA will not begin a substantive review of the application until a complete Full story available on Benzinga.com

U.S. stock index futures slid more than 1% on Tuesday before recouping some of those losses as fears of escalating tensions in Ukraine gripped markets, pointing to another volatile session on Wall Street.

NEW YORK, Feb. 9, 2022 /PRNewswire/ Full story available on Benzinga.com

Zosano Pharma (ZSAN) slumps 48.4% premarket after firm has priced its previously announced underwritten public offering of 51.25M units, each consisting of one share of common stock

The stock price of Zosano Pharma Corp (NASDAQ: ZSAN) fell by over 49% pre-market today. This is why it happened.

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 51,250,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, at a public offering price of $0.30 per unit. The warrants have an exercise price of $0.30 per share, are immediately exercisable and will expire five years from the date of issuance. Zosano has granted the underwriter a 30-day option to purchase up to an additional 7,687,500 shares of common stock and/or additional warrants to purchase up to 7,687,500 shares of common stock.

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwr

FREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it is commencing an underwritten public of

Zosano Pharma Corporation (NASDAQ:ZSAN) with the stream of 2.62% also noticed, India Outlook Therapeutics, Inc. (NASDAQ:OTLK) encountered a rapid change of -0.75% in the last hour of Fridays trading session. The post Sizzling Stock Update: Zosano Pharma Corporation (NASDAQ:ZSAN), Outlook Therapeutics, Inc. (NASDAQ:OTLK) appeared first on Stocks Equity .

—Data published in the Journal of Vaccines and Immunology— —Data published in the Journal of Vaccines and Immunology—

Zosano Pharma Corporation (NASDAQ: ZSAN) announced the publication of Phase 1 trial data of influenza vaccine in the Journal of Vaccines and Immunology.  The data demonstrated that a low dose of a

—Data published in the Journal of Vaccines and Immunology— —Data published in the Journal of Vaccines and Immunology—

Zosano Pharma Corp (ZSAN) shares closed today at 0.1% above its 52 week low of $0.48, giving the company a market cap of $57M. The stock is currently down 8.5% year-to-date, down 13.5% over the past 12 months, and down 96.8% over the past five years. This week, the Dow Jones Industrial Average rose 2.1%, and the S&P 500 rose 2.1%. Trading Activity Trading volume this week was 26.8% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by -133.7% The company's stock price performance over the past 12 months lags the peer average by -158.4% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Zosano Pharma Corporation (NASDAQ:ZSAN) with the stream of 0.13% also noticed, India Matinas BioPharma Holdings, Inc. (AMEX:MTNB) encountered a rapid change of -2.80% in the last hour of Thursdays trading The post Flaming Stock: Zosano Pharma Corporation (NASDAQ:ZSAN), Matinas BioPharma Holdings, Inc. (AMEX:MTNB) appeared first on Stocks Equity .

Zosano Pharma Co. (NASDAQ:ZSAN) crossed below its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.61 and traded as low as $0.54. Zosano Pharma shares last traded at $0.55, with a volume of 619,163 shares trading hands. The business has a 50 day moving average []